1e
19
1
49
2
2
18
1b
1d
18
36
76
1d
2 29
1d
25
Edward A. Stadtmauer, MD
78
76
Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor
28
95
3
5f
Co-Leader, Hematologic Malignancies Program, University of Pennsylvania Abramson Cancer Center
a3
Co-Leader, Hematologic Malignancies Translational Center of Excellence, Penn Medicine/Abramson Cancer Center
d1
Director of Hematologic Malignancies Clinical/Translational Research , Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
11
Department: Medicine
4
1
b
1d
46
Contact information
4e
4
3
3
3
2
4
b
1f
4e
Division of Hematology Oncology
2d Perelman Center for Advanced Medicine
22 12th Floor, South Pavilion
16 Office #12-171
39 3400 Civic Center Blvd
Philadelphia, PA 19104
26
2d Perelman Center for Advanced Medicine
22 12th Floor, South Pavilion
16 Office #12-171
39 3400 Civic Center Blvd
Philadelphia, PA 19104
2e
Office: 215-662-7910
32 Fax: 215-615-5888
24
8f
32 Fax: 215-615-5888
24
Email:
stadtmae@uphs.upenn.edu
12
stadtmae@uphs.upenn.edu
13
Education:
21 9 A.B. 19 (Biochemistry) c
49 Cornell University, College of Arts and Sciences, 1979.
21 9 M.D. 15 (Medicine) c
46 University of Pennsylvania School of Medicine, 1983.
c
3
3
3
3
8b
Permanent link21 9 A.B. 19 (Biochemistry) c
49 Cornell University, College of Arts and Sciences, 1979.
21 9 M.D. 15 (Medicine) c
46 University of Pennsylvania School of Medicine, 1983.
c
2 29
21
1e
1d
24
5e
65
1a 29
27
Description of Research Expertise
37 Clinical trials, Bone Marrow Transplant65
Description of Clinical Expertise
54 Myeloma, Leukemia, Lymphoma and Bone Marrow and Stem Cell Transplant1a 29
23
1a2 Rowe M, Babushok D, Carroll M, Carulli A, Frey N, Gill S, Hexner E, Hirsh R, Hossain N, Lai C, Loren A, Luger S, Maillard I, McCurdy S, Matthews A, Martin ME, Paralkar VR, Perl A, Porter D, Pratz K, Stadtmauer E, Bruno XJ.: Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen. Eur J Haematol Apr 2025.
12e Stalker M, Garfall A, Cohen A, Vogl DT, Djulbegovic M, Susanibar-Adaniya S, Stadtmauer E, Megherea O, Waxman AJ.: Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis. Eur J Haematol Mar 2025.
196 Banerjee R, Fritz AR, Akhtar OS, Freeman CL, Cowan AJ, Shah N, Landau HJ, Kumar SK, Vogl DT, Efebera YA, McCarthy PL, Vesole DH, Mendizabal A, Krishnan AY, Somlo G, Stadtmauer EA, Pasquini MC.: Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702. Leukemia Feb 2025.
15a Ho M, Paruzzo L, Minehart J, Voruganti T, Devi P, Vogl DT, Cohen AD, Garfall AL, Waxman AJ, Kapur S, Stadtmauer EA, Susanibar Adaniya S, Longworth S.: Nontuberculous mycobacterial infections following teclistamab in multiple myeloma. Haematologica 110: 1436-1442, Feb 2025.
397 Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang WT, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ramírez-Fernández Á, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA.: Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Nat Med Jan 2025.
15f Elghawy O, Deshpande S, Sussman J, Garfall A, Cohen A, Kapur S, Susanibar-Adaniya S, Vogl D, Waxman A, Stadtmauer E.: Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma. Bone Marrow Transplant Oct 2024.
1c4 Bhagwat AS, Torres L, Shestova O, Shestov M, Mellors PW, Fisher HR, Farooki SN, Frost BF, Loken MR, Gaymon AL, Frazee D, Rogal W, Frey N, Hexner EO, Luger SM, Loren AW, Martin ME, McCurdy SR, Perl AE, Stadtmauer EA, Brogdon JL, Fraietta JA, Hwang WT, Siegel DL, Plesa G, Aplenc R, Porter DL, June CH, Gill SI.: Cytokine-mediated CAR T therapy resistance in AML. Nat Med Sep 2024.
1e9 Malek, Ehsan, Kort, Jeries, Metheny, Leland, Fu, Pingfu, Li, Gen, Hari, Parameswaran, Efebera, Yvonne, Callander, Natalie S, Qazilbash, Muzaffar H, Giralt, Sergio, Krishnan, Amrita, Stadtmauer, Edward A, Lazarus, Hillard M: Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial. Transplant Cell Ther Jul 2024.
195 Hasanali ZS, Garfall AL, Burzenski L, Shultz LD, Tang Y, Kadu S, Sheppard NC, Liu W, Dopkin D, Vogl DT, Cohen AD, Waxman AJ, Susanibar-Adaniya SP, Carroll M, Stadtmauer EA, Allman D.: Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice. JCI Insight 9: e177300, May 2024.
2c
7
1d
1f
Selected Publications
11d Shan X, Kuiper R, Ding C, Munshi PN, Stadtmauer EA, Susanibar-Adaniya SP.: Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study. Haematologica May 2025.1a2 Rowe M, Babushok D, Carroll M, Carulli A, Frey N, Gill S, Hexner E, Hirsh R, Hossain N, Lai C, Loren A, Luger S, Maillard I, McCurdy S, Matthews A, Martin ME, Paralkar VR, Perl A, Porter D, Pratz K, Stadtmauer E, Bruno XJ.: Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen. Eur J Haematol Apr 2025.
12e Stalker M, Garfall A, Cohen A, Vogl DT, Djulbegovic M, Susanibar-Adaniya S, Stadtmauer E, Megherea O, Waxman AJ.: Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis. Eur J Haematol Mar 2025.
196 Banerjee R, Fritz AR, Akhtar OS, Freeman CL, Cowan AJ, Shah N, Landau HJ, Kumar SK, Vogl DT, Efebera YA, McCarthy PL, Vesole DH, Mendizabal A, Krishnan AY, Somlo G, Stadtmauer EA, Pasquini MC.: Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702. Leukemia Feb 2025.
15a Ho M, Paruzzo L, Minehart J, Voruganti T, Devi P, Vogl DT, Cohen AD, Garfall AL, Waxman AJ, Kapur S, Stadtmauer EA, Susanibar Adaniya S, Longworth S.: Nontuberculous mycobacterial infections following teclistamab in multiple myeloma. Haematologica 110: 1436-1442, Feb 2025.
397 Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang WT, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ramírez-Fernández Á, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA.: Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Nat Med Jan 2025.
15f Elghawy O, Deshpande S, Sussman J, Garfall A, Cohen A, Kapur S, Susanibar-Adaniya S, Vogl D, Waxman A, Stadtmauer E.: Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma. Bone Marrow Transplant Oct 2024.
1c4 Bhagwat AS, Torres L, Shestova O, Shestov M, Mellors PW, Fisher HR, Farooki SN, Frost BF, Loken MR, Gaymon AL, Frazee D, Rogal W, Frey N, Hexner EO, Luger SM, Loren AW, Martin ME, McCurdy SR, Perl AE, Stadtmauer EA, Brogdon JL, Fraietta JA, Hwang WT, Siegel DL, Plesa G, Aplenc R, Porter DL, June CH, Gill SI.: Cytokine-mediated CAR T therapy resistance in AML. Nat Med Sep 2024.
1e9 Malek, Ehsan, Kort, Jeries, Metheny, Leland, Fu, Pingfu, Li, Gen, Hari, Parameswaran, Efebera, Yvonne, Callander, Natalie S, Qazilbash, Muzaffar H, Giralt, Sergio, Krishnan, Amrita, Stadtmauer, Edward A, Lazarus, Hillard M: Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial. Transplant Cell Ther Jul 2024.
195 Hasanali ZS, Garfall AL, Burzenski L, Shultz LD, Tang Y, Kadu S, Sheppard NC, Liu W, Dopkin D, Vogl DT, Cohen AD, Waxman AJ, Susanibar-Adaniya SP, Carroll M, Stadtmauer EA, Allman D.: Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice. JCI Insight 9: e177300, May 2024.
2c